With this project we aim to develop Fourier transform-infrared (FTIR) qualitative and quantitative spectral analysis of normomethylated and hypomethylated DNA in mouse fibroblast cells treated and not with DNA demethylating agent, 5-azacytidine (5-AZA). We expect to obtain precise information regarding the quantification of DNA methylation profiles in mouse fibroblast cells by two independent methodologies: FTIR and HRM/sequencing, which will be in the same time a verification of the proof of principle for FTIR based analysis of the differences between normomethylated and hypomethylated genomic DNA which could be set as a potential predictive and diagnostic tool in future.
To our knowledge this is a first time that synchrotron-based FTIR micro-spectroscopy is used for detection of the presence of 5mC and changes in the DNA methylation profile in cells. Therefore, proposed project has the potential to set a methodological approach for estimating level of whole genome DNA methylation profile that could be used as potential tool in early diabetic diagnosis.
Project No.: 2018093034
Partner: ALBA Synchrotron, BL01 – MIRAS
Project period: 1 year (2019)
Coordinators: Dr. Melita Vidaković (Institute for Biological Research "Siniša Stanković") and Dr. Tanja Dučić (ALBA Synchrotron)
IBISS uses analytical cookies to analyze the use of the site in order to improve the user experience, by clicking "Accept" you consent to the use of cookies.